BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33477997)

  • 21. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
    Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29.
    Bartolini G; Ammar K; Mantovani B; Scanabissi F; Ferreri AM; Rocchi P; Orlandi M
    Anticancer Res; 2004; 24(3a):1779-83. PubMed ID: 15274355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.
    Pisano C; Kollar P; Gianní M; Kalac Y; Giordano V; Ferrara FF; Tancredi R; Devoto A; Rinaldi A; Rambaldi A; Penco S; Marzi M; Moretti G; Vesci L; Tinti O; Carminati P; Terao M; Garattini E
    Blood; 2002 Nov; 100(10):3719-30. PubMed ID: 12393712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic Diphenylacetylene-Based Retinoids Induce DNA Damage in Chinese Hamster Ovary Cells without Altering Viability.
    Hudhud L; Chisholm DR; Whiting A; Steib A; Pohóczky K; Kecskés A; Szőke É; Helyes Z
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation.
    Christie VB; Barnard JH; Batsanov AS; Bridgens CE; Cartmell EB; Collings JC; Maltman DJ; Redfern CP; Marder TB; Przyborski S; Whiting A
    Org Biomol Chem; 2008 Oct; 6(19):3497-507. PubMed ID: 19082150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
    Lin LM; Li BX; Xiao JB; Lin DH; Yang BF
    World J Gastroenterol; 2005 Sep; 11(36):5633-7. PubMed ID: 16237756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.
    Sun SY; Yue P; Shroot B; Hong WK; Lotan R
    J Cell Physiol; 1997 Nov; 173(2):279-84. PubMed ID: 9365537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
    Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
    Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
    J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
    Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoĭtova EV
    Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.
    Dawson MI; Fontana JA
    Mini Rev Med Chem; 2010 Jun; 10(6):455-91. PubMed ID: 20370709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis.
    Kello M; Drutovic D; Pilatova MB; Tischlerova V; Perjesi P; Mojzis J
    Life Sci; 2016 Apr; 150():32-8. PubMed ID: 26916824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells.
    Nicke B; Kaiser A; Wiedenmann B; Riecken EO; Rosewicz S
    Biochem Biophys Res Commun; 1999 Aug; 261(3):572-7. PubMed ID: 10441468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
    Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
    Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
    Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
    Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
    Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.